Academic Performance of Program Professors

The Program's tenured professors carry out diverse activities that significantly contribute to the Program's better performance. Some members participate in editorials of scientific journals and act as reviewers for important journals. Another activity of good expression is the participation of the teaching staff in qualifying and defending boards in Graduate Programs at UFPA, in Institutions in the North Region and other regions of the country. Even some work in boards abroad, in European Universities in Belgium and Portugal, for example.


Creation of the Center for Advanced Biodiversity Studies (CEABIO)

The project in progress since 2012 and concluded in 2018, created the headquarters building for the Center for Advanced Biodiversity Studies - CEABIO and the purchase of the necessary equipment to equip this space. The headquarters building was built to group UFPA's biodiversity research groups, which are dispersed. In addition to bringing these groups together, the new physical space increased their capacity allowing the development of a much larger volume of studies. This expansion allows researchers to separate activities so that they can work in better conditions for biosafety. The approximation of the various research groups, provided by their location in a single building, allows a greater integration between these groups, in the process of developing integrated works. This headquarters serves as a reference for the other groups located in the rest of the Amazon, being the physical landmark of biodiversity studies.



Research carried out at the Pharmaceutical Planning and Development Laboratory (LPDF), coordinated by Professor Cláudio Nahum Alves, has generated publications in scientific journals of international and national relevance, as well as the generation of patents. Research projects approved in the CAPES, FAPESPA and CNPq public notices have been supporting the studies. Highlighting the Malaria Network / PRONEX project that proposes the development of new inhibitors against Acquired Immunodeficiency Virus type 1 protease, HIV-1, in cooperation with groups of excellence in Biomolecule Synthesis and Biological and Toxicological Evaluation of new anti-drugs -HIV from the Birla Institute of Technology & Science of India and the School of Chemistry at the University of KwaZulu in South Africa. The project provided integration with groups of excellence in the field of pharmacological and toxicological assessment, and synthesis and isolation of potentially new substances active against malaria, complementing existing research on plasmodial enzymes.